0.0001USD0.00%Mkt Cap: 12678 USDP/E: —Last update: 2026-05-29
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap12.68K USD
Enterprise Value-15.46M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-56.93M USD
Revenue/Share—
Last Price0.0001 USD
Fiscal Year EndDec 2023
MR QuarterDec 2023
Employees57
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA0.28
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)-0.05
EPS (Forward)-0.38
52W Range
0.00010% of range0.2000
52W High0.2000 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-424.60%
ROA-128.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-57.24M USD
CapEx (TTM)803.00K USD
FCF Margin—
FCF Yield-294818.77%
Net Debt-15.47M USD
Net Debt/EBITDA0.28
Balance Sheet
Debt/Equity1.13
Current Ratio1.89
Quick Ratio1.76
Book Value/Sh0.1060 USD
Cash/Share0.2420 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.112.91M
Float112.87M
Insiders0.00%
Institutions0.02%
Short Interest
Short Ratio14.0d
Short % Float108.73%
Short % Out.3.33%
Shares Short4.22M
Short (prev mo.)3.85M
Technical
SMA 500.0021 (-95.3%)
SMA 2000.0056 (-98.2%)
Beta-74.18
S&P 52W Chg27.70%
Avg Vol (30d)5.61K
Avg Vol (10d)2.10K
Technical Indicators
RSI (14)47.3
MACD-0.0005
MACD Signal-0.0006
MACD Hist.+0.0001
BB Upper0.0004 USD
BB Middle0.0001 USD
BB Lower-0.0001 USD
BB Width351.76%
ATR (14)0.0148 USD
Vol Ratio (20d)0.00x